Annelotte van Bommel

188 Impact of 70-Gene Signature Use on Adjuvant Chemotherapy Decisions in Patients With Estrogen Receptor-Positive Early Breast Cancer: Results of a Prospective Cohort Study. Kuijer A, Straver M, den Dekker B, van Bommel ACM, Elias SG, Smorenburg CH, Wesseling J, Linn SC, Rutgers EJT, Siesling S, van Dalen T. J Clin Oncol. 2017 Aug 20;35(24):2814-2819. Breast magnetic resonance imaging use in patients undergoing neo-adjuvant chemotherapy is associated with less mastectomies in large ductal cancers but not in lobular cancers. Vriens IJH, Keymeulen K, Lobbes MBI, van Bommel ACM, Nieuwenhuijzen GAP, Smidt ML, Boersma LJ, van Dalen T, Smorenburg CH, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VCG; National Breast Cancer Organization of the Netherlands – Breast Cancer Audit Scientific Committee (NBCA). Eur J Cancer. 2017 Aug;81:74-80. Hospital organizational factors affect the use of immediate breast reconstruction after mastectomy for breast cancer in the Netherlands. Schreuder K, van Bommel ACM, de Ligt KM, Maduro JH, Vrancken Peeters MTFD, Mureau MAM, Siesling S. Breast. 2017 Aug;34:96-102. An International Collaborative Standardizing a Comprehensive Patient-Centered OutcomesMeasurement Set for Colorectal Cancer. Zerillo JA, SchouwenburgMG, van Bommel ACM, Stowell C, Lippa J, Bauer D, Berger AM, Boland G, Borras JM, Buss MK, Cima R, Van CutsemE, van Duyn EB, Finlayson SRG, Hung-Chun Cheng S, Langelotz C, Lloyd J, Lynch AC, Mamon HJ, McAllister PK, Minsky BD, Ngeow J, Abu HassanMR, Ryan K, Shankaran V, UptonMP, Zalcberg J, van de Velde CJ, Tollenaar R; Colorectal Cancer Working Group of the International Consortium for Health Outcomes Measurement (ICHOM). JAMA Oncol. 2017 May 1;3(5):686-694. Breast MRI increases the number of mastectomies for ductal cancers, but decreases them for lobular cancers. Lobbes MB, Vriens IJ, van Bommel AC, Nieuwenhuijzen GA, Smidt ML, Boersma LJ, van Dalen T, Smorenburg C, Struikmans H, Siesling S, Voogd AC, Tjan-Heijnen VC. Breast Cancer Res Treat. 2017 Apr;162(2):353-364.